Bluesphere Advisors’s AbbVie ABBV Stock Holding History

Bluesphere Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$384K	Sell	1,525 -31	-2%	-$6.67K	0.12%	78
2026 Q1	$338K	Buy	+1,556	New	+$345K	0.12%	86
2025 Q1	–	Sell	-3,812	Closed	-$677K	–	89
2024 Q4	$677K	Hold	3,812	–	–	0.33%	45
2024 Q3	$753K	Buy	3,812 +1	+0%	+$187	0.37%	40
2024 Q2	$654K	Buy	3,811 +1	+0%	+$166	0.33%	37
2024 Q1	$694K	Buy	3,810 +85	+2%	+$14.6K	0.38%	36
2023 Q4	$577K	Hold	3,725	–	–	0.36%	41
2023 Q3	$555K	Hold	3,725	–	–	0.4%	35
2023 Q2	$502K	Hold	3,725	–	–	0.35%	41
2023 Q1	$594K	Hold	3,725	–	–	0.49%	36
2022 Q4	$602K	Hold	3,725	–	–	0.53%	34
2022 Q3	$500K	Hold	3,725	–	–	0.5%	39
2022 Q2	$571K	Hold	3,725	–	–	0.55%	35
2022 Q1	$604K	Hold	3,725	–	–	0.51%	40
2021 Q4	$504K	Hold	3,725	–	–	0.42%	44
2021 Q3	$402K	Hold	3,725	–	–	0.39%	45
2021 Q2	$420K	Sell	3,725 -302	-7%	-$34K	0.37%	46
2021 Q1	$436K	Buy	4,027 +452	+13%	+$48.3K	0.39%	51
2020 Q4	$383K	Buy	+3,575	New	+$344K	0.41%	49

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bluesphere Advisors's ABBV Position: Q2 2026 in Review

Bluesphere Advisors reduced its AbbVie (ABBV) stake by 2% in Q2 2026, selling an estimated $6.67K and leaving 1,525 shares worth $384K. The position accounts for 0.12% of the portfolio, ranked #78.

Bluesphere Advisors first reported a position in ABBV in Q4 2020 and has held it in 19 quarters since. The position peaked at $753K in Q3 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Bluesphere Advisors held 1,525 shares of AbbVie worth $384K as of Q2 2026.
Bluesphere Advisors sold 31 AbbVie shares in Q2 2026, an estimated $6.67K.
AbbVie made up 0.12% of Bluesphere Advisors's portfolio in Q2 2026, its #78 holding.
Bluesphere Advisors first reported a position in AbbVie in Q4 2020 and has held it in 19 quarters since.
Bluesphere Advisors's AbbVie position peaked at $753K in Q3 2024.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bluesphere Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.